×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Why Does Drug Development Need Project Management?
Session Chair(s)
Timothy M. Phelan, PhD
Executive Director
Merck & Co., Inc., United States
Bringing a new medicine to patients is one of the truest examples of project management, yet the business results for large pharmaceuticals suggest we have not fully realized the business benefit of applying project management theory and practice. This session will discuss how maximizing the project management infrastructure already installed in drug development organizations will improve their business results.
Learning Objective : Describe how to drive business results with existing infrastructure; Discuss the balance between the art and science of project management; Explain real-world application.
Speaker(s)
Panelist
Vanessa Graham, MBA
Amgen Inc., United States
Executive Director, Global Program Management
Panelist
Jim L. Vandergriff
Eli Lilly and Company, United States
Manager, CTMS Supply Planning, CT Material Supply Chain Planning
Have an account?